A Study to Evaluate APX005M in Subjects With Unresectable or Metastatic Melanoma

Conditions:   Unresectable Melanoma;   Metastatic Melanoma Intervention:   Drug: APX005M Sponsor:   Apexigen, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials